Perhaps understandably, the published microarray analyses of the effects of EGF mainly focused on breast cancer and glioblastoma cell lines, the two types of cancer with EGFR-associated aetiology and have provided valuable data on the molecular effect of its action in several cell lines[13-15]. The gene discussed is EGFR; the disease is cancer.